Chakrachem Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 80.95%
- Profit Growth 109.29%
- Ebitda 109.22%
- Net Worth 19.21%
- Total Assets 302.63%
About Chakrachem Lifesciences
Chakrachem Lifesciences Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 April 2018 (Six years and ten months 18 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharathi Enugula and Rambabu Enugula serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999TG2018PTC123764
- Company No.
123764
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Chakrachem Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharathi Enugula  | Director | 11-Apr-2018 | Current |
| Rambabu Enugula | Director | 11-Apr-2018 | Current |
Financial Performance of Chakrachem Lifesciences.
Chakrachem Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 80.95% increase. The company also saw a substantial improvement in profitability, with a 109.29% increase in profit. The company's net worth Soared by an impressive increase of 19.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chakrachem Lifesciences?
Unlock access to Chakrachem Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Robomf Private LimitedBharathi Enugula is a mutual person
- Prajna Infolabs Private Limited
Bharathi Enugula is a mutual person
- Arogin Chemicals Private Limited
Bharathi Enugula is a mutual person
- Prajna Finserv Private Limited
Bharathi Enugula is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chakrachem Lifesciences?
Unlock and access historical data on people associated with Chakrachem Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chakrachem Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chakrachem Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.